Bank of Montreal Can Raises Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Bank of Montreal Can lifted its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 134.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,926 shares of the company’s stock after purchasing an additional 7,412 shares during the period. Bank of Montreal Can owned 0.13% of iShares U.S. Pharmaceuticals ETF worth $849,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its holdings in iShares U.S. Pharmaceuticals ETF by 2,176.8% during the fourth quarter. JPMorgan Chase & Co. now owns 188,567 shares of the company’s stock valued at $12,393,000 after purchasing an additional 180,285 shares during the period. Raymond James Financial Inc. bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $4,472,000. Pallas Capital Advisors LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $3,829,000. Strategic Financial Concepts LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $1,312,000. Finally, Grimes & Company Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $967,000.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE opened at $64.79 on Friday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $58.97 and a 1-year high of $73.28. The firm has a market cap of $589.59 million, a P/E ratio of 21.53 and a beta of 0.63. The company has a 50 day simple moving average of $68.50 and a two-hundred day simple moving average of $68.44.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.